Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.
Colebunders, Robert;
Tshomba, Antoine;
Van Kerkhove, Maria D;
Bausch, Daniel G;
Campbell, Pat;
Libande, Modeste;
Pirard, Patricia;
Tshioko, Florimond;
Mardel, Simon;
Mulangu, Sabue;
+6 more...Sleurs, Hilde;
Rollin, Pierre E;
Muyembe-Tamfum, Jean-Jacques;
Jeffs, Benjamin;
Borchert, Matthias;
International Scientific and Technical Committee "DRC Watsa/Durb;
(2007)
Marburg hemorrhagic fever in Durba and Watsa, Democratic Republic of the Congo: clinical documentation, features of illness, and treatment.
The Journal of infectious diseases, 196 Su (s2).
S148-S153.
ISSN 0022-1899
DOI: https://doi.org/10.1086/520543
Permanent Identifier
Use this Digital Object Identifier when citing or linking to this resource.
The objective of the present study was to describe day of onset and duration of symptoms of Marburg hemorrhagic fever (MHF), to summarize the treatments applied, and to assess the quality of clinical documentation. Surveillance and clinical records of 77 patients with MHF cases were reviewed. Initial symptoms included fever, headache, general pain, nausea, vomiting, and anorexia (median day of onset, day 1-2), followed by hemorrhagic manifestations (day 5-8+), and terminal symptoms included confusion, agitation, coma, anuria, and shock. Treatment in isolation wards was acceptable, but the quality of clinical documentation was unsatisfactory. Improved clinical documentation is necessary for a basic evaluation of supportive treatment.
